Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Two types of C/EBPα mutations play distinct but collaborative roles in leukemogenesis: lessons from clinical data and BMT models

Naoko Kato, Jiro Kitaura, Noriko Doki, Yukiko Komeno, Naoko Watanabe-Okochi, Katsuhiro Togami, Fumio Nakahara, Toshihiko Oki, Yutaka Enomoto, Yumi Fukuchi, Hideaki Nakajima, Yuka Harada, Hironori Harada, Toshio Kitamura

Blood (2011) 117 (1): 221–233.

https://doi.org/10.1182/blood-2010-02-270181

Published: 2011

Includes: Supplemental data

Journal Articles

Hes1 immortalizes committed progenitors and plays a role in blast crisis transition in chronic myelogenous leukemia

Fumio Nakahara, Mamiko Sakata-Yanagimoto, Yukiko Komeno, Naoko Kato, Tomoyuki Uchida, Kyoko Haraguchi, Keiki Kumano, Yuka Harada, Hironori Harada, Jiro Kitaura, Seishi Ogawa, Mineo Kurokawa, Toshio Kitamura, Shigeru Chiba

Blood (2010) 115 (14): 2872–2881.

https://doi.org/10.1182/blood-2009-05-222836

Published: 2010

Includes: Supplemental data

Journal Articles

Expansion of Inhibitory NK Receptor (CD94/NKG2A)-Expressing Cytolytic CD8 T Cells and CD4 + CD25 + Regulatory T Cells from the Same Cord Blood.

Junji Tanaka, MD, PhD, Junichi Sugita, MD, Naoko Kato, MD, PhD, Tomomi Toubai, MD, PhD, Jun Ibata, MD, Yusuke Shono, MD, Shuichi Ota, MD, PhD, Masahiro Asaka, MD, PhD, Masahiro Imamura, MD, PhD

Blood (2006) 108 (11): 1739.

https://doi.org/10.1182/blood.V108.11.1739.1739

Published: 2006

Journal Articles

Induction of the NKG2D Ligands Expression by Histone Deacetylase Inhibitor and Its Impact on the Susceptibility of Leukemic Cells to the Cytolytic Activity of NKG2D-Expressing Cells.

Naoko Kato, Junji Tanaka, Junichi Sugita, Tomomi Toubai, Yoko Miura, Makoto Ibata, Yusuke Shono, Shuichi Ota, Takeshi Kondo, Masahiro Asaka, Masahiro Imamura

Blood (2006) 108 (11): 924.

https://doi.org/10.1182/blood.V108.11.924.924

Published: 2006

Journal Articles

Analysis of TREC (T Cell Receptor Excision Circles) Levels in CD94 Expressing CD8 T Cells in Chronic GVHD.

Noriaki Iwao, MD, Junji Tanaka, MD, Naoko Kato, MD, Takeshi Kondo, MD, Yoko Miura, MD, Tomomi Toubai, MD, Akio Shigematsu, MD, Keiichi Kondo, MD, Shuichi Ohta, MD, Masahiro Asaka, MD, Masahiro Imamura, MD

Blood (2005) 106 (11): 5367.

https://doi.org/10.1182/blood.V106.11.5367.5367

Published: 2005

Journal Articles

Kinetics of Serum Macrophage Migration Inhibitory Factor (MIF) and Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) in Allogeneic Stem Cell Transplantation.

Tomomi Toubai, Junji Tanaka, Shuichi Ota, Junichi Sugita, Naoko Kato, Keiichi Kondo, Noriaki Iwao, Masahiro Asaka, Masahiro Imamura

Blood (2005) 106 (11): 5343.

https://doi.org/10.1182/blood.V106.11.5343.5343

Published: 2005

Journal Articles

Expression of the Chk2 Gene Is Downregulated in Hodgkin’s Lymphoma Cell Lines Via Epigenetic Mechanisms.

Naoko Kato, MD, Takeshi Kondo, MD, Junichi Tsukada, MD, Yoshiya Tanaka, MD, Yasuhiro Minami, MD, Junji Tanaka, MD, Masahiro Imamura, MD

Blood (2004) 104 (11): 429.

https://doi.org/10.1182/blood.V104.11.429.429

Published: 2004

Journal Articles

Expansion of Inhibitory NK Receptor (CD94/NKG2A)-Expressing CD8 T Cells from Various Blood Mononuclear Cells with Cytolytic Activity Against Primary Leukemic Cells.

Junji Tanaka, MD, Noriaki Iwao, MD, Tomomi Toubai, MD, Yoko Miura, MD, Naoko Kato, MD, Akio Shigematsu, MD, Keichi Kondo, MD, Shuichi Ota, MD, Masahiro Asaka, MD, Masahiro Imamura, MD

Blood (2004) 104 (11): 4967.

https://doi.org/10.1182/blood.V104.11.4967.4967

Published: 2004

Journal Articles

Cytolytic activity and regulatory functions of inhibitory NK cell receptor–expressing T cells expanded from granulocyte colony-stimulating factor–mobilized peripheral blood mononuclear cells

Junji Tanaka, Tomomi Toubai, Yutaka Tsutsumi, Yoko Miura, Naoko Kato, Shintarou Umehara, Kaoru Kahata, Akio Mori, Nobuyasu Toyoshima, Shuichi Ota, Takahiko Kobayashi, Masanobu Kobayashi, Masaharu Kasai, Masahiro Asaka, Masahiro Imamura

Blood (2004) 104 (3): 768–774.

https://doi.org/10.1182/blood-2003-11-3870

Published: 2004

NARROW

Two types of C/EBPα mutations play distinct but collaborative roles in leukemogenesis: lessons from clinical data and BMT models

Hes1 immortalizes committed progenitors and plays a role in blast crisis transition in chronic myelogenous leukemia

Expansion of Inhibitory NK Receptor (CD94/NKG2A)-Expressing Cytolytic CD8 T Cells and CD4 + CD25 + Regulatory T Cells from the Same Cord Blood.

Induction of the NKG2D Ligands Expression by Histone Deacetylase Inhibitor and Its Impact on the Susceptibility of Leukemic Cells to the Cytolytic Activity of NKG2D-Expressing Cells.

Analysis of TREC (T Cell Receptor Excision Circles) Levels in CD94 Expressing CD8 T Cells in Chronic GVHD.

Kinetics of Serum Macrophage Migration Inhibitory Factor (MIF) and Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) in Allogeneic Stem Cell Transplantation.

Expression of the Chk2 Gene Is Downregulated in Hodgkin’s Lymphoma Cell Lines Via Epigenetic Mechanisms.

Expansion of Inhibitory NK Receptor (CD94/NKG2A)-Expressing CD8 T Cells from Various Blood Mononuclear Cells with Cytolytic Activity Against Primary Leukemic Cells.

Cytolytic activity and regulatory functions of inhibitory NK cell receptor–expressing T cells expanded from granulocyte colony-stimulating factor–mobilized peripheral blood mononuclear cells

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only